Shift in brain metabolism in late onset Alzheimer's disease: Implications for biomarkers and therapeutic interventions

Molecular Aspects of Medicine

Volumn 32, Issue 4-6, 2011, Pages 247-257

  Yao, Jia ^a   Rettberg, Jamaica R ^a   Klosinski, Lauren P ^a   Cadenas, Enrique ^a   Brinton, Roberta Diaz ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Bioenergetics; Biomarkers; Mitochondria; Oxidative stress; White matter degeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; GLUCOSE; RESVERATROL; TAU PROTEIN; THIOCTIC ACID;

AGING; ALZHEIMER DISEASE; ARTICLE; BIOENERGY; BRAIN DEGENERATION; BRAIN METABOLISM; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; WHITE MATTER;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; BRAIN; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 81855164838     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2011.10.005     Document Type: Article

References (129)

1. R.A. Armstrong The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis" Int. J. Alzheimers Dis. 2011 630865
2. Alzheimer's Association, A.s., 2011. 2011 Alzheimer's Disease Facts and Figures 12.
3. H. Atamna, and W.H. Frey 2nd Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease Mitochondrion 7 5 2007 297 310 (Pubitemid 47300175)
4. N. Auestad, R.A. Korsak, J.W. Morrow, and J. Edmond Fatty acid oxidation and ketogenesis by astrocytes in primary culture J. Neurochem. 56 4 1991 1376 1386 (Pubitemid 21902060)
5. G. Bartzokis, D. Sultzer, P.H. Lu, K.H. Nuechterlein, J. Mintz, and J.L. Cummings Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease Neurobiol. Aging 25 7 2004 843 851 (Pubitemid 38813164)
6. M.F. Beal Mitochondria take center stage in aging and neurodegeneration Ann. Neurol. 58 4 2005 495 505 (Pubitemid 41377212)
7. A.W. Bero, P. Yan, J.H. Roh, J.R. Cirrito, F.R. Stewart, M.E. Raichle, J.M. Lee, and D.M. Holtzman Neuronal activity regulates the regional vulnerability to amyloid-beta deposition Nat. Neurosci. 14 6 2011 750 756
8. J.P. Blass The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome Ann. N. Y. Acad. Sci. 924 2000 170 183 (Pubitemid 32050199)
9. K. Blennow, E. Vanmechelen, and H. Hampel CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease Mol. Neurobiol. 24 1-3 2001 87 97 (Pubitemid 34066679)
10. F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Siciliano, E.A. Tendi, L. Murri, S.I. Rapoport, and G. Solaini Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol. Aging 23 3 2002 371 376 (Pubitemid 34312019)
11. R.D. Brinton Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease Adv. Drug Deliv. Rev. 60 13-14 2008 1504 1511
12. M. Burns, K. Gaynor, V. Olm, M. Mercken, J. LaFrancois, L. Wang, P.M. Mathews, W. Noble, Y. Matsuoka, and K. Duff Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo J. Neurosci. 23 13 2003 5645 5649 (Pubitemid 36807842)
13. S.M. Cardoso, S. Santos, R.H. Swerdlow, and C.R. Oliveira Functional mitochondria are required for amyloid beta-mediated neurotoxicity FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 15 8 2001 1439 1441
14. S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana, and C.R. Oliveira Cytochrome c oxidase is decreased in Alzheimer's disease platelets Neurobiol. Aging 25 1 2004 105 110 (Pubitemid 37522198)
15. O. Carmichael, C. Schwarz, D. Drucker, E. Fletcher, D. Harvey, L. Beckett, C.R. Jack Jr., M. Weiner, and C. DeCarli Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative Arch. Neurol. 67 11 2010 1370 1378
16. J. Casademont, O. Miro, B. Rodriguez-Santiago, P. Viedma, R. Blesa, and F. Cardellach Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease J. Neurol. Sci. 206 1 2003 23 26 (Pubitemid 35448073)
17. K. Chen, E.M. Reiman, G.E. Alexander, R.J. Caselli, R. Gerkin, D. Bandy, A. Domb, D. Osborne, N. Fox, W.R. Crum, A.M. Saunders, and J. Hardy Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates Am. J. Psychiatry 164 6 2007 916 921 (Pubitemid 46972907)
18. G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, F. Eustache, and J.C. Baron Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60 8 2003 1374 1377 (Pubitemid 36461002)
19. S.R. Choi, G. Golding, Z. Zhuang, W. Zhang, N. Lim, F. Hefti, T.E. Benedum, M.R. Kilbourn, D. Skovronsky, and H.F. Kung Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 50 11 2009 1887 1894
20. J.L. Chou, D.V. Shenoy, N. Thomas, P.K. Choudhary, F.M. Laferla, S.R. Goodman, and G.A. Breen Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease J. Proteomics 74 4 2011 466 479
21. Consensus report of the Working Group on: "Molecular, Biochemical Markers of Alzheimer's Disease" The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group Neurobiol. Aging 19 2 1998 109 116
22. M.J. de Leon, A. Convit, O.T. Wolf, C.Y. Tarshish, S. DeSanti, H. Rusinek, W. Tsui, E. Kandil, A.J. Scherer, A. Roche, A. Imossi, E. Thorn, M. Bobinski, C. Caraos, P. Lesbre, D. Schlyer, J. Poirier, B. Reisberg, and J. Fowler Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose/poitron-emission tomography (FDG/PET) Proc. Natl Acad. Sci. USA 98 19 2001 10966 10971 (Pubitemid 32878727)
23. G. De Meyer, F. Shapiro, H. Vanderstichele, E. Vanmechelen, S. Engelborghs, P.P. De Deyn, E. Coart, O. Hansson, L. Minthon, H. Zetterberg, K. Blennow, L. Shaw, and J.Q. Trojanowski Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Arch. Neurol. 67 8 2010 949 956
24. S. De Santi, M.J. de Leon, H. Rusinek, A. Convit, C.Y. Tarshish, A. Roche, W.H. Tsui, E. Kandil, M. Boppana, K. Daisley, G.J. Wang, D. Schlyer, and J. Fowler Hippocampal formation glucose metabolism and volume losses in MCI and AD Neurobiol. Aging 22 4 2001 529 539 (Pubitemid 32607736)
25. F.F. Diana, A.R. Silva Esteves, C.R. Oliveira, and S.M. Cardoso Mitochondria: the common upstream driver of Abeta and tau pathology in Alzheimers disease Curr. Alzheimer Res. 8 5 2011 563 572
26. H. Du, L. Guo, S. Yan, A.A. Sosunov, G.M. McKhann, and S.S. Yan Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model Proc. Natl Acad. Sci. USA 107 43 2010 18670 18675
27. M. Dumont, M.T. Lin, and M.F. Beal Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease J. Alzheimers Dis. 20 Suppl. 2 2010 S633 643
28. S.D. Edland, J.M. Silverman, E.R. Peskind, D. Tsuang, E. Wijsman, and J.C. Morris Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance Neurology 47 1 1996 254 256 (Pubitemid 26243893)
29. K. Fassbender, C. Masters, and K. Beyreuther Alzheimer's disease: molecular concepts and therapeutic targets Naturwissenschaften 88 6 2001 261 267 (Pubitemid 32721516)
30. P. Feldhaus, D.B. Fraga, F.V. Ghedim, R.D. De Luca, T.D. Bruna, M. Heluany, M.P. Matos, G.K. Ferreira, I.C. Jeremias, C. Heluany, E.L. Streck, and A.I. Zugno Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease Metab. Brain Dis. 26 3 2011 229 236
31. G.E. Gibson, and Q. Shi A mitocentric view of Alzheimer's disease suggests multi-faceted treatments J. Alzheimers Dis. 20 Suppl. 2 2010 S591 607
32. G.E. Gibson, K.F. Sheu, J.P. Blass, A. Baker, K.C. Carlson, B. Harding, and P. Perrino Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease Arch. Neurol. 45 8 1988 836 840
33. T.E. Golde, L.S. Schneider, and E.H. Koo Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift Neuron 69 2 2011 203 213
34. M. Guzman, and C. Blazquez Ketone body synthesis in the brain: possible neuroprotective effects Prostaglandins Leukot. Essent. Fatty Acids 70 3 2004 287 292 (Pubitemid 38200955)
35. H. Hampel, K. Burger, S.J. Teipel, A.L. Bokde, H. Zetterberg, and K. Blennow Core candidate neurochemical and imaging biomarkers of Alzheimer's disease Alzheimers Dement. 4 1 2008 38 48
36. O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow, and L. Minthon Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol. 5 3 2006 228 234 (Pubitemid 43238346)
37. J. Hardy Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal J. Alzheimers Dis. 9 3 Suppl. 2006 151 153 (Pubitemid 44253307)
38. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 5054 1992 184 185
39. S. Hauptmann, I. Scherping, S. Drose, U. Brandt, K.L. Schulz, M. Jendrach, K. Leuner, A. Eckert, and W.E. Muller Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice Neurobiol. Aging 30 10 2009 1574 1586
40. S.T. Henderson Ketone bodies as a therapeutic for Alzheimer's disease Neurotherapeutics 5 3 2008 470 480 (Pubitemid 351952488)
41. S. Hoyer, R. Nitsch, and K. Oesterreich Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases J. Neural Transm. Park. Dis. Dement. Sect. 3 1 1991 1 14
42. V. Ibanez, P. Pietrini, G.E. Alexander, M.L. Furey, D. Teichberg, J.C. Rajapakse, S.I. Rapoport, M.B. Schapiro, and B. Horwitz Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease Neurology 50 6 1998 1585 1593 (Pubitemid 28283222)
43. M.D. Ikonomovic, W.E. Klunk, E.E. Abrahamson, C.A. Mathis, J.C. Price, N.D. Tsopelas, B.J. Lopresti, S. Ziolko, W. Bi, W.R. Paljug, M.L. Debnath, C.E. Hope, B.A. Isanski, R.L. Hamilton, and S.T. DeKosky Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain: J. Neurol. 131 Pt 6 2008 1630 1645 (Pubitemid 351806448)
44. B.P. Imbimbo, and G.A. Giardina gamma-Secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes Curr. Top. Med. Chem. 11 12 2011 1555 1570
45. K. Ishii, M. Sasaki, H. Kitagaki, S. Yamaji, S. Sakamoto, K. Matsuda, and E. Mori Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease J. Nucl. Med. 38 6 1997 925 928 (Pubitemid 27251986)
46. C.R. Jack Jr., V.J. Lowe, M.L. Senjem, S.D. Weigand, B.J. Kemp, M.M. Shiung, D.S. Knopman, B.F. Boeve, W.E. Klunk, C.A. Mathis, and R.C. Petersen 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain: J. Neurol. 131 Pt 3 2008 665 680 (Pubitemid 351294719)
47. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, R.C. Petersen, and J.Q. Trojanowski Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol. 9 1 2010 119 128
48. W. Jagust, A. Gitcho, F. Sun, B. Kuczynski, D. Mungas, and M. Haan Brain imaging evidence of preclinical Alzheimer's disease in normal aging Ann. Neurol. 59 4 2006 673 681
49. T. Kanno, and T. Nishizaki Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3/-9 via a mitochondrial pathway linked to SDK/14-3-3 protein/Bax/cytochrome c J. Cell. Physiol. 226 9 2011 2329 2337
50. S.S. Karuppagounder, J.T. Pinto, H. Xu, H.L. Chen, M.F. Beal, and G.E. Gibson Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease Neurochem. Int. 54 2 2009 111 118
51. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker Jr., and J.P. Bennett Jr. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways Ann. Neurol. 48 2 2000 148 155 (Pubitemid 30617032)
52. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D.P. Holt, M. Bergstrom, I. Savitcheva, G.F. Huang, S. Estrada, B. Ausen, M.L. Debnath, J. Barletta, J.C. Price, J. Sandell, B.J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C.A. Mathis, and B. Langstrom Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55 3 2004 306 319 (Pubitemid 38269583)
53. D.S. Knopman, J.E. Parisi, A. Salviati, M. Floriach-Robert, B.F. Boeve, R.J. Ivnik, G.E. Smith, D.W. Dickson, K.A. Johnson, L.E. Petersen, W.C. McDonald, H. Braak, and R.C. Petersen Neuropathology of cognitively normal elderly J. Neuropathol. Exp. Neurol. 62 11 2003 1087 1095 (Pubitemid 37413820)
54. B. Kuczynski, E. Targan, C. Madison, M. Weiner, Y. Zhang, B. Reed, H.C. Chui, and W. Jagust White matter integrity and cortical metabolic associations in aging and dementia Alzheimers Dement. 6 1 2010 54 62
55. V. Leinonen, I. Alafuzoff, S. Aalto, T. Suotunen, S. Savolainen, K. Nagren, T. Tapiola, T. Pirttila, J. Rinne, J.E. Jaaskelainen, H. Soininen, and J.O. Rinne Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B Arch. Neurol. 65 10 2008 1304 1309
56. F. Li, N.Y. Calingasan, F. Yu, W.M. Mauck, M. Toidze, C.G. Almeida, R.H. Takahashi, G.A. Carlson, M. Flint Beal, M.T. Lin, and G.K. Gouras Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice J. Neurochem. 89 5 2004 1308 1312 (Pubitemid 38715849)
57. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 7113 2006 787 795 (Pubitemid 44622683)
58. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 5669 2004 448 452 (Pubitemid 38495942)
59. P.J. Magistretti Neuron-glia metabolic coupling and plasticity J. Exp. Biol. 209 Pt 12 2006 2304 2311 (Pubitemid 44065524)
60. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 15 9 2006 1437 1449
61. P. Marambaud, H. Zhao, and P. Davies Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides J. Biol. Chem. 280 45 2005 37377 37382 (Pubitemid 41642343)
62. M.A. Mintun, G.N. Larossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, R.H. Mach, W.E. Klunk, C.A. Mathis, S.T. DeKosky, and J.C. Morris [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 3 2006 446 452 (Pubitemid 44214969)
63. J.A. Molina, F. de Bustos, F.J. Jimenez-Jimenez, J. Benito-Leon, T. Gasalla, M. Orti-Pareja, L. Vela, F. Bermejo, M.A. Martin, Y. Campos, and J. Arenas Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease Neurology 48 3 1997 636 638 (Pubitemid 27120098)
64. P.I. Moreira, S.M. Cardoso, M.S. Santos, and C.R. Oliveira The key role of mitochondria in Alzheimer's disease J. Alzheimers Dis. 9 2 2006 101 110 (Pubitemid 44078638)
65. P.I. Moreira, M.S. Santos, R. Seica, and C.R. Oliveira Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes J. Neurol. Sci. 257 1-2 2007 206 214 (Pubitemid 46856489)
66. P.I. Moreira, X. Zhu, X. Wang, H.G. Lee, A. Nunomura, R.B. Petersen, G. Perry, and M.A. Smith Mitochondria: a therapeutic target in neurodegeneration Biochim. Biophys. Acta 1802 1 2010 212 220
67. A.A. Morris Cerebral ketone body metabolism J. Inherit. Metab. Dis. 28 2 2005 109 121 (Pubitemid 40723878)
68. L. Mosconi, S. De Santi, J. Li, W.H. Tsui, Y. Li, M. Boppana, E. Laska, H. Rusinek, and M.J. de Leon Hippocampal hypometabolism predicts cognitive decline from normal aging Neurobiol. Aging 29 5 2008 676 692 (Pubitemid 351400830)
69. L. Mosconi, R. Mistur, R. Switalski, M. Brys, L. Glodzik, K. Rich, E. Pirraglia, W. Tsui, S. De Santi, and M.J. de Leon Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease Neurology 72 6 2009 513 520
70. L. Mosconi, R. Mistur, R. Switalski, W.H. Tsui, L. Glodzik, Y. Li, E. Pirraglia, S. De Santi, B. Reisberg, T. Wisniewski, and M.J. de Leon FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease Eur. J. Nucl. Med. Mol. Imaging 36 5 2009 811 822
71. L. Mosconi, M. de Leon, J.E.L. Murray, J. Lu, E. Javier, P. McHugh, and R.H. Swerdlow Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease J. Alzheimers Dis. 2011 (Epub ahead of print)
72. L. Mosconi, W. Tsui, J. Murray, P. McHugh, Y. Li, S. Williams, E. Pirraglia, L. Glodzik, S. De Santi, S. Vallabhajosula, and M.J. de Leon Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease Neurobiol. Aging 2011 (Epub ahead of print)
73. R.M. Nicholson, Y. Kusne, L.A. Nowak, F.M. LaFerla, E.M. Reiman, and J. Valla Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models Brain Res. 1347 2010 179 185
74. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 8 2001 759 767 (Pubitemid 32678256)
75. A. Nunomura, S. Chiba, C.F. Lippa, P. Cras, R.N. Kalaria, A. Takeda, K. Honda, M.A. Smith, and G. Perry Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease Neurobiol. Dis. 17 1 2004 108 113 (Pubitemid 39209318)
76. A. Nunomura, T. Hofer, P.I. Moreira, R.J. Castellani, M.A. Smith, and G. Perry RNA oxidation in Alzheimer disease and related neurodegenerative disorders Acta Neuropathol. 118 1 2009 151 166
77. L. O'Dwyer, F. Lamberton, A.L. Bokde, M. Ewers, Y.O. Faluyi, C. Tanner, B. Mazoyer, D. O'Neill, M. Bartley, D.R. Collins, T. Coughlan, D. Prvulovic, and H. Hampel Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease PLoS ONE 6 6 2011 e21745
78. L. Packer, and E. Cadenas Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling J. Clin. Biochem. Nutr. 48 1 2011 26 32
79. L.C. Park, H. Zhang, K.F. Sheu, N.Y. Calingasan, B.S. Kristal, J.G. Lindsay, and G.E. Gibson Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia J. Neurochem. 72 5 1999 1948 1958 (Pubitemid 29185998)
80. W.D. Parker Jr. Cytochrome oxidase deficiency in Alzheimer's disease Ann. N. Y. Acad. Sci. 640 1991 59 64
81. W.D. Parker Jr., C.M. Filley, and J.K. Parks Cytochrome oxidase deficiency in Alzheimer's disease Neurology 40 8 1990 1302 1303 (Pubitemid 20244999)
82. W.D. Parker Jr., N.J. Mahr, C.M. Filley, J.K. Parks, D. Hughes, D.A. Young, and C.M. Cullum Reduced platelet cytochrome c oxidase activity in Alzheimer's disease Neurology 44 6 1994 1086 1090 (Pubitemid 24188183)
83. E.K. Perry, R.H. Perry, B.E. Tomlinson, G. Blessed, and P.H. Gibson Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase Neurosci. Lett. 18 1 1980 105 110 (Pubitemid 10122792)
84. S.S. Petanceska, S. DeRosa, V. Olm, N. Diaz, A. Sharma, T. Thomas-Bryant, K. Duff, M. Pappolla, and L.M. Refolo Statin therapy for Alzheimer's disease: will it work? J. Mol. Neurosci. 19 1-2 2002 155 161 (Pubitemid 35013349)
85. S.W. Pimplikar Reassessing the amyloid cascade hypothesis of Alzheimer's disease Int. J. Biochem. Cell Biol. 41 6 2009 1261 1268
86. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 12 2001 4183 4187 (Pubitemid 32538543)
87. J.L. Price, and J.C. Morris Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann. Neurol. 45 3 1999 358 368 (Pubitemid 29120041)
88. N.D. Prins, P.J. Visser, and P. Scheltens Can novel therapeutics halt the amyloid cascade? Alzheimers Res. Ther. 2 2 2010 5
89. R.D. Readnower, A.D. Sauerbeck, and P.G. Sullivan Mitochondria, amyloid beta, and Alzheimer's disease Int. J. Alzheimers Dis. 2011 104545
90. P.H. Reddy Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics J. Biomed. Biotechnol. 3 2006 31372
91. P.H. Reddy, and M.F. Beal Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends Mol. Med. 14 2 2008 45 53
92. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc. Natl Acad. Sci. USA 101 1 2004 284 289 (Pubitemid 38084242)
93. V. Rhein, X. Song, A. Wiesner, L.M. Ittner, G. Baysang, F. Meier, L. Ozmen, H. Bluethmann, S. Drose, U. Brandt, E. Savaskan, C. Czech, J. Gotz, and A. Eckert Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice Proc. Natl Acad. Sci. USA 106 47 2009 20057 20062
94. S.L. Risacher, A.J. Saykin, J.D. West, L. Shen, H.A. Firpi, and B.C. McDonald Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort Curr. Alzheimer Res. 6 4 2009 347 361
95. R.F. Rosen, B.J. Ciliax, T.S. Wingo, M. Gearing, J. Dooyema, J.J. Lah, J.A. Ghiso, H. LeVine 3rd, and L.C. Walker Deficient high-affinity binding of Pittsburgh Compound B in a case of Alzheimer's disease Acta Neuropathol. 119 2 2010 221 233
96. M.H. Rosenbloom, A. Alkalay, N. Agarwal, S.L. Baker, J.P. O'Neil, M. Janabi, I.V. Yen, M. Growdon, J. Jang, C. Madison, E.C. Mormino, H.J. Rosen, M.L. Gorno-Tempini, M.W. Weiner, B.L. Miller, W.J. Jagust, and G.D. Rabinovici Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution Neurology 76 12 2011 1789 1796
97. L.S. Schneider, K.S. Dagerman, J.P. Higgins, and R. McShane Lack of evidence for the efficacy of memantine in mild Alzheimer disease Arch. Neurol. 68 8 2011 991 998
98. L.S. Schneider, P.S. Insel, and M.W. Weiner Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's disease neuroimaging initiative Arch. Neurol. 68 1 2011 58 66
99. D.F. Silva, A.R. Esteves, D.M. Arduino, C.R. Oliveira, and S.M. Cardoso Amyloid-beta-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway J. Alzheimers Dis. 26 3 2011 565 581
100. A.M. Simon, D. Frechilla, and J. del Rio Perspectives on the amyloid cascade hypothesis of Alzheimer's disease Rev. Neurol. 50 11 2010 667 675
101. B. Sommer Alzheimer's disease and the amyloid cascade hypothesis: ten years on Curr. Opin. Pharmacol. 2 1 2002 87 92
102. S. Sorbi, E.D. Bird, and J.P. Blass Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain Ann. Neurol. 13 1 1983 72 78 (Pubitemid 13224203)
103. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, T. Iwatsubo, C.R. Jack Jr., J. Kaye, T.J. Montine, D.C. Park, E.M. Reiman, C.C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M.C. Carrillo, B. Thies, M. Morrison-Bogorad, M.V. Wagster, and C.H. Phelps Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement. 7 3 2011 280 292
104. G. Spulber, E. Niskanen, S. Macdonald, O. Smilovici, K. Chen, E.M. Reiman, A.M. Jauhiainen, M. Hallikainen, S. Tervo, L.O. Wahlund, R. Vanninen, M. Kivipelto, and H. Soininen Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease Neurobiol. Aging 31 9 2008 1601 1605
105. A.A. Starkov, G. Fiskum, C. Chinopoulos, B.J. Lorenzo, S.E. Browne, M.S. Patel, and M.F. Beal Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species J. Neurosci. 24 36 2004 7779 7788 (Pubitemid 39215681)
106. R.H. Swerdlow Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies J. Neurosci. Res. 85 15 2007 3416 3428 (Pubitemid 350058530)
107. R.H. Swerdlow, and S.M. Khan A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease Med. Hypotheses 63 1 2004 8 20 (Pubitemid 38887104)
108. R.H. Swerdlow, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis: an update Exp. Neurol. 218 2 2009 308 315
109. R.H. Swerdlow, J.M. Burns, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis J. Alzheimers Dis. 20 Suppl. 2 2010 S265 279
110. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy, A.C. Trillat, D.M. Stern, O. Arancio, and S.S. Yan ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction FASEB J. 19 6 2005 597 598 (Pubitemid 40471256)
111. J.Q. Trojanowski, H. Vandeerstichele, M. Korecka, C.M. Clark, P.S. Aisen, R.C. Petersen, K. Blennow, H. Soares, A. Simon, P. Lewczuk, R. Dean, E. Siemers, W.Z. Potter, M.W. Weiner, C.R. Jack Jr., W. Jagust, A.W. Toga, V.M. Lee, and L.M. Shaw Update on the biomarker core of the Alzheimer's disease neuroimaging initiative subjects Alzheimers Dement. 6 3 2010 230 238
112. E. Trushina, and C.T. McMurray Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases Neuroscience 145 4 2007 1233 1248 (Pubitemid 46602738)
113. S.N. Vaishnavi, A.G. Vlassenko, M.M. Rundle, A.Z. Snyder, M.A. Mintun, and M.E. Raichle Regional aerobic glycolysis in the human brain Proc. Natl. Acad. Sci. USA 107 41 2010 17757 17762
114. J. Valla, L. Schneider, T. Niedzielko, K.D. Coon, R. Caselli, M.N. Sabbagh, G.L. Ahern, L. Baxter, G. Alexander, D.G. Walker, and E.M. Reiman Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment Mitochondrion 6 6 2006 323 330 (Pubitemid 44817367)
115. K.S. Vetrivel, and G. Thinakaran Membrane rafts in Alzheimer's disease beta-amyloid production Biochim. Biophys. Acta 1801 8 2010 860 867
116. N. Villain, M. Fouquet, J.C. Baron, F. Mezenge, B. Landeau, V. de La Sayette, F. Viader, F. Eustache, B. Desgranges, and G. Chetelat Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease Brain 133 11 2010 3301 3314
117. V. Vingtdeux, U. Dreses-Werringloer, H. Zhao, P. Davies, and P. Marambaud Therapeutic potential of resveratrol in Alzheimer's disease BMC Neurosci. 9 Suppl. 2 2008 S6
118. A.G. Vlassenko, S.N. Vaishnavi, L. Couture, D. Sacco, B.J. Shannon, R.H. Mach, J.C. Morris, M.E. Raichle, and M.A. Mintun Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition Proc. Natl. Acad. Sci. USA 107 41 2010 17763 17767
119. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Annu. Rev. Genet. 39 2005 359 407 (Pubitemid 43011120)
120. J. Wang, S. Xiong, C. Xie, W.R. Markesbery, and M.A. Lovell Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease J. Neurochem. 93 4 2005 953 962 (Pubitemid 40695754)
121. J.L. Whitwell, S.A. Przybelski, S.D. Weigand, D.S. Knopman, B.F. Boeve, R.C. Petersen, and C.R. Jack Jr. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain 130 Pt 7 2007 1777 1786 (Pubitemid 47343806)
122. R. Williams Biomarkers: warning signs Nature 475 7355 2011 S5 7
123. K.A. Wollen Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners Altern. Med. Rev. 15 3 2010 223 244
124. D.F. Wong, P.B. Rosenberg, Y. Zhou, A. Kumar, V. Raymont, H.T. Ravert, R.F. Dannals, A. Nandi, J.R. Brasic, W. Ye, J. Hilton, C. Lyketsos, H.F. Kung, A.D. Joshi, D.M. Skovronsky, and M.J. Pontecorvo In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18) J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 51 6 2010 913 920
125. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 106 34 2009 14670 14675
126. J. Yao, R.T. Hamilton, E. Cadenas, and R.D. Brinton Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence Biochim. Biophys. Acta 1800 10 2010 1121 1126
127. J. Yao, S. Chen, Zisu Mao, Enrique Cadenas, and Roberta Diaz Brinton 2-Deoxy-d-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease PLoS One 6 7 2011 e21788
128. K.J. Young, and J.P. Bennett The mitochondrial secret(ase) of Alzheimer's disease J. Alzheimers Dis. 20 Suppl. 2 2010 S381 400
129. Y. Zhang, N. Schuff, G.H. Jahng, W. Bayne, S. Mori, L. Schad, S. Mueller, A.T. Du, J.H. Kramer, K. Yaffe, H. Chui, W.J. Jagust, B.L. Miller, and M.W. Weiner Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease Neurology 68 1 2007 13 19 (Pubitemid 46058544)